|
1
|
Moran EM and Mastaglia FL: Cytokines in
immune-mediated inflammatory myopathies: Cellular sources, multiple
actions and therapeutic implications. Clin Exp Immunol.
178:405–415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoeppli RE, Wu D, Cook L and Levings MK:
The environment of regulatory T cell biology: Cytokines,
metabolites and the microbiome. Front Immunol. 6:612015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Venkatesha SH, Dudics S, Acharya B and
Moudgil KD: Cytokine-modulating strategies and newer cytokine
targets for arthritis therapy. Int J Mol Sci. 16:887–906. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garlanda C, Dinarello CA and Mantovani A:
The interleukin-1 family: Back to the future. Immunity.
39:1003–1018. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dinarello CA: Interleukin-1 in the
pathogenesis and treatment of inflammatory diseases. Blood.
117:3720–3732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith DE: The biological paths of IL-1
family members IL-18 and IL-33. J Leukoc Biol. 89:383–392. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dinarello C, Arend W, Sims J, Smith D,
Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H,
Bufler P, et al: IL-1 family nomenclature. Nat Immunol. 11:9732010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moretti S, Bozza S, Oikonomou V, Renga G,
Casagrande A, Iannitti RG, Puccetti M, Garlanda C, Kim S, Li S, et
al: IL-37 inhibits inflammasome activation and disease severity in
murine aspergillosis. PLoS Pathog. 10:e10044622014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boraschi D, Lucchesi D, Hainzl S, Leitner
M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C,
Posselt G, et al: IL-37: A new anti-inflammatory cytokine of the
IL-1 family. Eur Cytokine Netw. 22:127–147. 2011.PubMed/NCBI
|
|
10
|
Taylor SL, Renshaw BR, Garka KE, Smith DE
and Sims JE: Genomic organization of the interleukin-1 locus.
Genomics. 79:726–733. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye L and Huang Z: IL-37 restrains
autoimmune diseases. Oncotarget. 6:21775–21776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S, An W, Yao Y, Chen R, Zheng X, Yang
W, Zhao Y, Hu X, Jiang E, Bie Y, et al: Interleukin 37 expression
inhibits STAT3 to Suppress the proliferation and invasion of human
cervical cancer cells. J Cancer. 6:962–969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Wang Z, Yu T, Chen B, Zhang J, Huang
K and Huang Z: Increased expression of IL-37 in patients with
Graves' disease and its contribution to suppression of
proinflammatory cytokines production in peripheral blood
mononuclear cells. PLoS One. 9:e1071832014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Deng L, Chen Y, Sun C, Wang J, Zhou
L, Li H and Luo R: Anti-inflammatory effect of IL-37b in children
with allergic rhinitis. Mediators Inflamm. 2014:7468462014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murzin AG, Lesk AM and Chothia C:
Beta-Trefoil fold. patterns of structure and sequence in the kunitz
inhibitors interleukins-1 beta and 1 alpha and fibroblast growth
factors. J Mol Biol. 223:531–543. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banchereau J, Pascual V and O'Garra A:
From IL-2 to IL-37: The expanding spectrum of anti-inflammatory
cytokines. Nat Immunol. 13:925–931. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nold MF, Nold-Petry CA, Zepp JA, Palmer
BE, Bufler P and Dinarello CA: IL-37 is a fundamental inhibitor of
innate immunity. Nat Immunol. 11:1014–1022. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Busfield SJ, Comrack CA, Yu G, Chickering
TW, Smutko JS, Zhou H, Leiby KR, Holmgren LM, Gearing DP and Pan Y:
Identification and gene organization of three novel members of the
IL-1 family on human chromosome 2. Genomics. 66:213–216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smith DE, Renshaw BR, Ketchem RR, Kubin M,
Garka KE and Sims JE: Four new members expand the interleukin-1
superfamily. J Biol Chem. 275:1169–1175. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ross R, Grimmel J, Goedicke S, Möbus AM,
Bulau AM, Bufler P, Ali S and Martin MU: Analysis of nuclear
localization of interleukin-1 family cytokines by flow cytometry. J
Immunol Methods. 387:219–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akdis M, Burgler S, Crameri R, Eiwegger T,
Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, et
al: Interleukins, from 1 to 37 and interferon-γ: Receptors,
functions and roles in diseases. J Allergy Clin Immunol.
127:701–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Imaeda H, Takahashi K, Fujimoto T, Kasumi
E, Ban H, Bamba S, Sonoda H, Shimizu T, Fujiyama Y and Andoh A:
Epithelial expression of interleukin-37b in inflammatory bowel
disease. Clin Exp Immunol. 172:410–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan G, Risser P, Mao W, Baldwin DT, Zhong
AW, Filvaroff E, Yansura D, Lewis L, Eigenbrot C, Henzel WJ and
Vandlen R: IL-1H, an interleukin 1-related protein that binds IL-18
receptor/IL-1Rrp. Cytokine. 13:1–7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bufler P, Gamboni-Robertson F, Azam T, Kim
SH and Dinarello CA: Interleukin-1 homologues IL-1F7b and IL-18
contain functional mRNA instability elements within the coding
region responsive to lipopolysaccharide. Biochem J. 381:503–510.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kumar S, McDonnell PC, Lehr R, Tierney L,
Tzimas MN, Griswold DE, Capper EA, Tal-Singer R, Wells GI, Doyle ML
and Young PR: Identification and initial characterization of four
novel members of the interleukin-1 family. J Biol Chem.
275:10308–10314. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dunn E, Sims JE, Nicklin MJ and O'Neill
LA: Annotating genes with potential roles in the immune system: Six
new members of the IL-1 family. Trends Immunol. 22:533–536. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bufler P, Azam T, Gamboni-Robertson F,
Reznikov LL, Kumar S, Dinarello CA and Kim SH: A complex of the
IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18
activity. Proc Natl Acad Sci USA. 99:pp. 13723–13728. 2002;
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Wang Y, Liu Y, Wang Y, Zuo X, Li Y
and Lu X: The possible role of the novel cytokines il-35 and il-37
in inflammatory bowel disease. Mediators Inflamm. 2014:1363292014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sharma S, Kulk N, Nold MF, Gräf R, Kim SH,
Reinhardt D, Dinarello CA and Bufler P: The IL-1 family member 7b
translocates to the nucleus and down-regulates proinflammatory
cytokines. J Immunol. 180:5477–5482. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He L, Liang Z, Zhao F, Peng L and Chen Z:
Modulation of IL-37 expression by triptolide and triptonide in
THP-1 cells. Cell Mol Immunol. 12:515–518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McNamee EN, Masterson JC, Jedlicka P,
McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P,
Dinarello CA and Rivera-Nieves J: Interleukin 37 expression
protects mice from colitis. Proc Natl Acad Sci USA. 108:pp.
16711–16716. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Su S, Duan J, Chen T, Huang X, Shang E, Yu
L, Wei K, Zhu Y, Guo J, Guo S, et al: Frankincense and myrrh
suppress inflammation via regulation of the metabolic profiling and
the MAPK signaling pathway. Sci Rep. 5:136682015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo C, Xia Y, Niu P, Jiang L, Duan J, Yu
Y, Zhou X, Li Y and Sun Z: Silica nanoparticles induce oxidative
stress, inflammation and endothelial dysfunction in vitro via
activation of the MAPK/Nrf2 pathway and nuclear factor-κB
signaling. Int J Nanomedicine. 10:1463–1477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang HU, Zhang HH, Yang BX, Huang JL, Shun
JL, Kong FJ, Peng-Xu, Chen ZG and Lu JM: Cdk5 contributes to
inflammation-induced thermal hyperalgesia mediated by the p38 MAPK
pathway in microglia. Brain Res. 1619:166–175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lei YY, Wang WJ, Mei JH and Wang CL:
Mitogen-activated protein kinase signal transduction in solid
tumors. Asian Pac J Cancer Prev. 15:8539–8548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grossi V, Peserico A, Tezil T and Simone
C: p38α MAPK pathway: A key factor in colorectal cancer therapy and
chemoresistance. World J Gastroenterol. 20:9744–9758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jha SK, Jha NK, Kar R, Ambasta RK and
Kumar P: p38 MAPK and PI3K/AKT signalling cascades inparkinson's
disease. Int J Mol Cell Med. 4:67–86. 2015.PubMed/NCBI
|
|
38
|
Lupia E, Pigozzi L, Goffi A, Hirsch E and
Montrucchio G: Role of phosphoinositide 3-kinase in the
pathogenesis of acute pancreatitis. World J Gastroenterol.
20:15190–15199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yip PY: Phosphatidylinositol
3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR)
signaling pathway in non-small cell lung cancer. Transl Lung Cancer
Res. 4:165–176. 2015.PubMed/NCBI
|
|
40
|
Huang Z, Zhao GW, Gao CH, Chi XW, Zeng T,
Hu YW, Zheng L and Wang Q: Mannose-capped lipoarabinomannan from
mycobacterium tuberculosis induces Il-37 production via
upregulating ERK1/2 and p38 in human type II alveolar epithelial
cells. Int J Clin Exp Med. 8:7279–7287. 2015.PubMed/NCBI
|
|
41
|
Rudloff I, Cho SX, Lao JC, Ngo D, McKenzie
M, Nold-Petry CA and Nold MF: Monocytes and dendritic cells are the
primary sources of interleukin 37 in human immune cells. J Leukoc
Bio. 101:901–911. 2016. View Article : Google Scholar
|
|
42
|
Gunaltay S, Ghiboub M, Hultgren O and
Hörnquist EH: Reduced IL-37 production increases spontaneous
chemokine expressions in colon epithelial cells. Dig Dis Sci.
62:1204–1215. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Smithrithee R, Niyonsaba F, Kiatsurayanon
C, Ushio H, Ikeda S, Okumura K and Ogawa H: Human β-defensin-3
increases the expression of interleukin-37 through CCR6 in human
keratinocytes. J Dermatol Sci. 77:46–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang Y, Zhang ZX, Lian D, Haig A,
Bhattacharjee RN and Jevnikar AM: IL-37 inhibits IL-18-induced
tubular epithelial cell expression of pro-inflammatory cytokines
and renal ischemia-reperfusion injury. Kidney Int. 87:396–408.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie Y, Li Y, Cai X, Wang X and Li J:
Interleukin-37 suppresses ICAM-1 expression in parallel with NF-κB
down-regulation following TLR2 activation of human coronary artery
endothelial cells. Int immunopharmacolo. 38:26–30. 2016. View Article : Google Scholar
|
|
46
|
Coll-Miró M, Francos-Quijorna I,
Santos-Nogueira E, Torres-Espin A, Bufler P, Dinarello CA and
López-Vales R: Beneficial effects of IL-37 after spinal cord injury
in mice. Proc Natl Acad Sci USA. 113:pp. 1411–1416. 2016;
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu M, Guo S, Hibbert JM, Jain V, Singh N,
Wilson NO and Stiles JK: CXCL10/IP-10 in infectious diseases
pathogenesis and potential therapeutic implications. Cytokine
Growth Factor Rev. 22:121–130. 2011.PubMed/NCBI
|
|
48
|
Zhao M, Hu Y, Shou J, Su SB, Yang J and
Yang T: IL-37 impairs host resistance to listeria infection by
suppressing macrophage function. Biochem Biophys Res Commun.
485:563–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li S, Neff CP, Barber K, Hong J, Luo Y,
Azam T, Palmer BE, Fujita M, Garlanda C, Mantovani A, et al:
Extracellular forms of IL-37 inhibit innate inflammation in vitro
and in vivo but require the IL-1 family decoy receptor IL-1R8. Proc
Natl Acad Sci USA. 112:pp. 2497–2502. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zaccone P, Fehervari Z, Blanchard L,
Nicoletti F, Edwards CK III and Cooke A: Autoimmune thyroid disease
induced by thyroglobulin and lipopolysaccharide is inhibited by
soluble TNF receptor type I. Eur J Immunol. 32:1021–1028. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dujmovic I, Mangano K, Pekmezovic T,
Quattrocchi C, Mesaros S, Stojsavljevic N, Nicoletti F and Drulovic
J: The analysis of IL-1 beta and its naturally occurring inhibitors
in multiple sclerosis: The elevation of IL-1 receptor antagonist
and IL-1 receptor type II after steroid therapy. J Neuroimmunol.
207:101–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nicoletti F, Patti F, DiMarco R, Zaccone
P, Nicoletti A, Meroni P and Reggio A: Circulating serum levels of
IL-1ra in patients with relapsing remitting multiple sclerosis are
normal during remission phases but significantly increased either
during exacerbations or in response to IFN-beta treatment.
Cytokine. 8:395–400. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nicoletti F, Zaccone P, Di Marco R,
Lunetta M, Magro G, Grasso S, Meroni P and Garotta G: Prevention of
spontaneous autoimmune diabetes in diabetes-prone BB rats by
prophylactic treatment with antirat interferon-gamma antibody.
Endocrinology. 138:281–288. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nicoletti F, Di Marco R, Barcellini W,
Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P
and Meroni P: Protection from experimental autoimmune diabetes in
the non-obese diabetic mouse with soluble interleukin-1 receptor.
Eur J Immunol. 24:1843–1847. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Akdis M, Aab A, Altunbulakli C, Azkur K,
Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R,
et al: Interleukins (from IL-1 to IL-38), interferons, transforming
growth factor β and TNF-α: Receptors, functions and roles in
diseases. J Allergy Clin Immunol. 138:984–1010. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Højen JF, Rasmussen TA, Andersen KL,
Winckelmann AA, Laursen RR, Gunst JD, Møller HJ, Fujita M,
Østergaard L, Søgaard OS, et al: Interleukin-37 expression is
increased in chronic HIV-1-Infected individuals and is associated
with inflammation and the size of the total viral reservoir. Mol
Med. 21:337–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wan ZY, Sun Z, Song F, Chen YF, Zhang WL,
Wang HQ and Luo ZJ: Downregulated interleukin 37 expression
associated with aggravation of intervertebral disc degeneration.
Int J Clin Exp Pathol. 7:656–662. 2014.PubMed/NCBI
|
|
58
|
Günaltay S, Nyhlin N, Kumawat AK, Tysk C,
Bohr J, Hultgren O and Hultgren Hörnquist E: Differential
expression of interleukin-1/Toll-like receptor signaling regulators
in microscopic and ulcerative colitis. World J Gastroenterol.
20:12249–12259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen B, Huang K, Ye L, Li Y, Zhang J,
Zhang J, Fan X, Liu X, Li L, Sun J, et al: Interleukin-37 is
increased in ankylosing spondylitis patients and associated with
disease activity. J Transl Med. 13:362015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu
T, Chen B, Zhang J, Ding L, et al: IL-37 inhibits the production of
inflammatory cytokines in peripheral blood mononuclear cells of
patients with systemic lupus erythematosus: Its correlation with
disease activity. J Transl Med. 12:692014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ji Q, Zeng Q, Huang Y, Shi Y, Lin Y, Lu Z,
Meng K, Wu B, Yu K, Chai M, et al: Elevated plasma IL-37, IL-18 and
IL-18BP concentrations in patients with acute coronary syndrome.
Mediators Inflamm. 2014:1657422014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang X, Cai X, Chen L, Xu D and Li J: The
evaluation of plasma and leukocytic IL-37 expression in early
inflammation in patients with acute ST-segment elevation myocardial
infarction after PCI. Mediators Inflamm. 2015:6269342015.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yu K, Min X, Lin Y, Huang Y, Huang S, Liu
L, Peng Y, Meng K, Li D, Ji Q and Zeng Q: Increased IL-37
concentrations in patients with arterial calcification. Clin Chim
Acta. 461:19–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhao JJ, Pan QZ, Pan K, Weng DS, Wang QJ,
Li JJ, Lv L, Wang DD, Zheng HX and Jiang SS: Interleukin-37
mediates the antitumor activity in hepatocellular carcinoma: Role
for CD57+ NK cells. Sci Rep. 4:51772014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ge G, Wang A, Yang J, Chen Y, Yang J, Li Y
and Xue Y: Interleukin-37 suppresses tumor growth through
inhibition of angiogenesis in non-small cell lung cancer. J Exp
Clin Cancer Res. 35:132016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wu BW, Zeng QT, Meng K and Ji QW: The
potential role of IL-37 in atherosclerosis. Pharmazie. 68:857–860.
2013.PubMed/NCBI
|
|
67
|
Sakai N, Van Sweringen HL, Belizaire RM,
Quillin RC, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ
and Lentsch AB: Interleukin-37 reduces liver inflammatory injury
via effects on hepatocytes and non-parenchymal cells. J
Gastroenterol Hepatol. 27:1609–1616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Luo Y, Cai X, Liu S, Wang S, Nold-Petry
CA, Nold MF, Bufler P, Norris D, Dinarello CA and Fujita M:
Suppression of antigen-specific adaptive immunity by IL-37 via
induction of tolerogenic dendritic cells. Proc Natl Acad Sci USA.
111:pp. 15178–15183. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Jethwa H and Bowness P: The interleukin
(IL)-23/IL-17 axis in ankylosing spondylitis: New advances and
potentials for treatment. Clin Exp Immunol. 138:30–36. 2016.
View Article : Google Scholar
|
|
70
|
Ballak DB, van Diepen JA, Moschen AR,
Jansen HJ, Hijmans A, Groenhof GJ, Leenders F, Bufler P,
Boekschoten MV, Müller M, et al: IL-37 protects against
obesity-induced inflammation and insulin resistance. Nat Commun.
5:47112014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Burdo TH, Lentz MR, Autissier P, Krishnan
A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ and Williams KC:
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV
activity in early and chronic infection prior to and after
anti-retroviral therapy. J Infect Dis. 204:154–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sandler NG, Wand H, Roque A, Law M, Nason
MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, et al:
Plasma levels of soluble CD14 independently predict mortality in
HIV infection. J Infect Dis. 203:780–790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wu GC, Li HM, Wang JB, Leng RX, Wang DG
and Ye DQ: Elevated plasma interleukin-37 levels in systemic lupus
erythematosus patients. Lupus. 25:1377–1380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Song L, Qiu F, Fan Y, Ding F, Liu H, Shu
Q, Liu W and Li X: Glucocorticoid regulates interleukin-37 in
systemic lupus erythematosus. J Clin Immunol. 33:111–117. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yang T, Fang F, Chen Y, Ma J, Xiao Z, Zou
S, Zheng N, Yan D, Liao S, Chen S, et al: Elevated plasma
interleukin-37 playing an important role in acute coronary syndrome
through suppression of ROCK activation. Oncotarget. 8:9686–9695.
2017.PubMed/NCBI
|
|
76
|
Liu K, Tang Q, Zhu X and Yang X: IL-37
increased in patients with acute coronary syndrome and associated
with a worse clinical outcome after ST-segment elevation acute
myocardial infarction. Clin Chim Acta. 468:140–144. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Xu D, Wang A, Jiang F, Hu J and Zhang X:
Effects of interleukin-37 on cardiac function after myocardial
infarction in mice. Int J Clin Exp Pathol. 8:5247–5251.
2015.PubMed/NCBI
|
|
78
|
Zhang XQ, Tang R, Li L, Szucsik A, Javan
H, Saegusa N, Spitzer KW and Selzman CH: Cardiomyocyte-specific p65
NF-kappaB deletion protects the injured heart by preservation of
calcium handling. Am J Physiol Heart Circ Physiol. 305:H1089–H1097.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zeng M, Wei X, Wu Z, Li W, Li B, Zhen Y,
Chen J, Wang P and Fei Y: NF-κB-mediated induction of autophagy in
cardiac ischemia/reperfusion injury. Biochem Biophys Res Commun.
436:180–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li J, Zhai Y, Ao L, Hui H, Fullerton DA,
Dinarello CA and Meng X: Interleukin-37 suppresses the inflammatory
response to protect cardiac function in old endotoxemic mice.
Cytokine. 95:55–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ding VA, Zhu Z, Xiao H, Wakefield MR, Bai
Q and Fang Y: The role of IL-37 in cancer. Med Oncol. 33:682016.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Abulkhir A, Samarani S, Amre D, Duval M,
Haddad E, Sinnett D, Leclerc JM, Diorio C and Ahmad A: A protective
role of IL-37 in cancer: A new hope for cancer patients. J Leukoc
Biol. 101:395–406. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Moretta L, Pietra G, Montaldo E, Vacca P,
Pende D, Falco M, Del Zotto G, Locatelli F, Moretta A and Mingari
MC: Human NK cells: From surface receptors to the therapy of
leukemias and solid tumors. Front Immunol. 5:872014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Kunz M and Ibrahim SM: Cytokines and
cytokine profiles in human autoimmune diseases and animal models of
autoimmunity. Mediators Inflamm. 2009:9792582009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Semerano L, Assier E and Boissier MC:
Anti-cytokine vaccination: A new biotherapy of autoimmunity?
Autoimmun Rev. 11:785–786. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Taylor PC and Williams RO: Combination
cytokine blockade: The way forward in therapy for rheumatoid
arthritis? Arthritis Rheumatol. 67:14–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Striz I, Brabcova E, Kolesar L and
Sekerkova A: Cytokine networking of innate immunity cells: A
potential target of therapy. Clin Sci (Lond). 126:593–612. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Gao W, Kumar S, Lotze MT, Hanning C,
Robbins PD and Gambotto A: Innate immunity mediated by the cytokine
IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive
and profound antitumor immunity. J Immunol. 170:107–113. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yin D, Naji DH, Xia Y, Li S, Bai Y, Jiang
G, Zhao Y, Wang X, Huang Y, Chen S, et al: Genomic Variant in IL-37
confers a significant risk of coronary artery disease. Scientific
reports. 7:421752017. View Article : Google Scholar : PubMed/NCBI
|
